Cargando…
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
Cardiogenic shock is characterized by tissue hypoxia caused by circulatory failure arising from inadequate cardiac output. In addition to treating the pathologic process causing impaired cardiac function, prompt hemodynamic support is essential to reduce the risk of developing multiorgan dysfunction...
Autores principales: | Bloom, Jason E., Chan, William, Kaye, David M., Stub, Dion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492962/ https://www.ncbi.nlm.nih.gov/pubmed/37489740 http://dx.doi.org/10.1161/JAHA.123.029787 |
Ejemplares similares
-
Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”?
por: Morici, Nuccia, et al.
Publicado: (2016) -
The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
por: Ryu, Rachel, et al.
Publicado: (2022) -
Cardiogenic Shock
por: Vahdatpour, Cyrus, et al.
Publicado: (2019) -
Real-life use of vasopressors and inotropes in cardiogenic shock—observation is necessarily ‘theory-laden’
por: Ray, Samiran, et al.
Publicado: (2016) -
Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis
por: Karami, Mina, et al.
Publicado: (2020)